Additionally, SETDB2 overexpression observed both in vitro and in vivo in pre-BCR+ ALL was found to suppress expression of the cell-cycle inhibitor CDKN2C through H3K9me3 in E2A-PBX1+ B-ALL [133]. This evidence concerns the gene BCR and acute lymphoblastic leukemia.